Earnings Releases·Oct 28, 2026, 6:25 AM ET

GE HealthCare — Third Quarter 2026 Earnings Summary

Total revenues reached $5.5 billion, up 7.2% year-over-year, while net income and adjusted EBIT rose to $615 million and $913 million respectively, driving diluted EPS to $1.36 (up 39.1%) and expanding net income and adjusted EBIT margins by 250 and 180 basis points.
The company raised full-year 2026 guidance across all key metrics, increasing organic revenue growth to ~4.0%, adjusted EBIT margin to 15.5%–15.7%, adjusted EPS to $4.95–$5.05, and free cash flow to $1.6 billion or more.
Strategic capital allocation included a $945 million cash acquisition of SOFIE Biosciences expected to close in H1 2027, a 14% dividend increase to $0.04 per share, and $300 million in common stock repurchases over the first nine months.
All business segments delivered double-digit margin expansion driven by volume, pricing, and cost productivity, supported by a backlog of $23.7 billion and a book-to-bill ratio of 1.03.